{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:07:55Z","timestamp":1787958475280,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.diagmicrobio.2023.116118","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:58:42Z","timestamp":1698357522000},"page":"116118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the Performance of the Dynamiker Fungus (1-3)-\u03b2-D-Glucan and Fungitell Assay for Diagnosis of Candidemia: Need for New Cut-off Development and Test Validation"],"prefix":"10.1016","volume":"108","author":[{"given":"Somayeh","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahbarmah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Motamedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116118_bib0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10156-007-0595-7","article-title":"Current challenges in the management of invasive fungal infections","volume":"14","author":"Lai","year":"2008","journal-title":"J Infect Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116118_bib0002","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clinical Infect Diseases"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2023.116118_bib0003","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clinical Infect Diseases"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2023.116118_bib0004","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1309\/LM8BW8QNV7NZBROG","article-title":"(1\u20133)-\u03b2-D-glucan assay: a review of its laboratory and clinical application","volume":"42","author":"Wright","year":"2011","journal-title":"Laboratory Medicine"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2023.116118_bib0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3390\/jof7121046","article-title":"Beta-D-Glucan in Patients with Haematological Malignancies","volume":"7","author":"Mikulska","year":"2021","journal-title":"J Fungi"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2023.116118_bib0006","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JCM.01737-13","article-title":"Point-counterpoint: \u03b2-d-glucan testing is important for diagnosis of invasive fungal infections","volume":"51","author":"Theel","year":"2013","journal-title":"J Clinical Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2023.116118_bib0007","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Diseases"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116118_bib0008","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5858\/arpa.2014-0230-RS","article-title":"Application of the 1, 3-\u03b2-d-glucan (Fungitell) assay in the diagnosis of invasive fungal infections","volume":"140","author":"Tran","year":"2016","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"Supplement_1","key":"10.1016\/j.diagmicrobio.2023.116118_bib0009","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1\u2192 3)-\u03b2-D-glucan in the diagnosis of invasive aspergillosis","volume":"47","author":"Marty","year":"2009","journal-title":"Medical Mycol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.116118_bib0010","article-title":"(1\u2192 3)-\u03b2-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people","author":"White","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.116118_bib0011","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.03567-13","article-title":"Use and limits of (1-3)-\u03b2-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis","volume":"52","author":"Sulahian","year":"2014","journal-title":"J Clinical Microbiol"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2023.116118_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00464-18","article-title":"Comparative analysis of the Wako \u03b2-glucan test and the Fungitell assay for diagnosis of candidemia and Pneumocystis jirovecii pneumonia","volume":"56","author":"Friedrich","year":"2018","journal-title":"J Clinical Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116118_bib0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ajcp\/aqy135","article-title":"Diagnostic accuracy of \u03b2-d-glucan (Fungitell) testing among patients with hematologic malignancies or solid organ tumors: a systematic review and meta-analysis","volume":"151","author":"White","year":"2019","journal-title":"American J Clinical Pathol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2023.116118_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01691-22","article-title":"Comparison of three \u03b2-glucan tests for the diagnosis of invasive candidiasis in intensive care units","volume":"61","author":"Kritikos","year":"2023","journal-title":"J Clinical Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116118_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.01240-10","article-title":"Prospective survey of (1\u2192 3)-\u03b2-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting","volume":"49","author":"Mohr","year":"2011","journal-title":"J Clinical Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116118_bib0016","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40121-022-00627-7","article-title":"Evaluation of the Dynamiker\u00ae Fungus (1\u20133)-\u03b2-D-glucan assay for the diagnosis of invasive aspergillosis in high-risk patients with hematologic malignancies","volume":"11","author":"Siopi","year":"2022","journal-title":"Infectious Diseases and Therapy"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116118_bib0017","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/mmy\/myx097","article-title":"An evaluation of the performance of the Dynamiker\u00ae Fungus (1-3)-\u03b2-D-Glucan Assay to assist in the diagnosis of Pneumocystis pneumonia","volume":"56","author":"White","year":"2018","journal-title":"Medical Mycol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116118_bib0018","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clinical Infect Diseases"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2023.116118_bib0019","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1, 3-\u03b2-D-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116118_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1, 3-\u03b2-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J Clinical Microbiol"},{"key":"10.1016\/j.diagmicrobio.2023.116118_bib0021","series-title":"26th European Congress of Clinical Microbiology and Infectious Diseases","article-title":"Performance of the Dynamiker\u00ae(1-3)-\u03b2-D-glucan assay compared to Fungitell\u00ae for the diagnosis of invasive fungal disease from serum samples","author":"Wang","year":"2016"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2023.116118_bib0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/mmy\/myx004","article-title":"An evaluation of the performance of the Dynamiker\u00ae Fungus (1-3)-\u03b2-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia","volume":"55","author":"White","year":"2017","journal-title":"Medical Mycol"},{"key":"10.1016\/j.diagmicrobio.2023.116118_bib0023","first-page":"1","article-title":"Evaluation of the Dynamiker\u00ae Fungus (1\u20133)-\u03b2-d-Glucan Assay for the Diagnosis of Invasive Aspergillosis in High-Risk Patients with Hematologic Malignancies","author":"Siopi","year":"2022","journal-title":"Infect Diseases and Therapy"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2023.116118_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc13953","article-title":"Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation","volume":"18","author":"Poissy","year":"2014","journal-title":"Critical Care"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2023.116118_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00025-07","article-title":"Quantification of 1, 3-\u03b2-D-glucan levels in children: preliminary data for diagnostic use of the \u03b2-glucan assay in a pediatric setting","volume":"14","author":"Smith","year":"2007","journal-title":"Clinical and Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2023.116118_bib0026","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/527382","article-title":"1, 3-\u03b2-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia","volume":"46","author":"Senn","year":"2008","journal-title":"Clinical Infect Diseases"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116118_bib0027","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/mmy\/myx021","article-title":"Evaluation of the (1, 3)-\u03b2-D-glucan assay for the diagnosis of neonatal invasive yeast infections","volume":"56","author":"Cornu","year":"2018","journal-title":"Medical Mycol"},{"key":"10.1016\/j.diagmicrobio.2023.116118_bib0028","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jped.2017.07.020","article-title":"Role of serum (1, 3)-\u03b2-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit","volume":"94","author":"Shabaan","year":"2018","journal-title":"J de Pediatria"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2023.116118_bib0029","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/14767058.2012.722716","article-title":"(1\u20133)-\u03b2-D-glucan levels in candidiasis infections in the critically ill neonate","volume":"26","author":"Goudjil","year":"2013","journal-title":"J Maternal-Fetal & Neonatal Medicine"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889323002274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889323002274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:59:58Z","timestamp":1760003998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889323002274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0732889323002274"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.116118","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Performance of the Dynamiker Fungus (1-3)-\u03b2-D-Glucan and Fungitell Assay for Diagnosis of Candidemia: Need for New Cut-off Development and Test Validation","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.116118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116118"}}